ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

ERAXIS
Fungal infections
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

REMOVE SELECTED | COMPARE SELECTED

Drug Name:

ERAXIS Rx

Generic Name and Formulations:
Anidulafungin 50mg/vial, 100mg/vial; pwd for IV infusion after reconstitution and dilution; preservative-free; contains fructose and mannitol.

Company:
Pfizer Inc.

e-Prescribe this drug via Surescripts


Therapeutic Use:

Product Resources »
  • Product Information
  • Coupons, Samples & Vouchers
  • Patient Education and Assistance

RECENT UPDATES

01/07/13
Updated Warnings/Precautions regarding anaphylactic reactions.

Indications for ERAXIS:

Candidemia. Esophageal candidiasis. Other Candida infections (intra-abdominal abscess, peritonitis).

Adult Dose for ERAXIS:

Give by IV infusion; max rate 1.1mg/minute. Candidiasis, intra-abdominal abscess, peritonitis: 200mg on day 1, then 100mg/day for at least 14 days after last positive culture. Esophageal candidiasis: 100mg on day 1, then 50mg/day for at least 14 days and at least 7 days after symptom resolution.

Children's Dose for ERAXIS:

≤16yrs: not established.

Pharmacological Class:

Glucan synthesis inhibitor (echinocandin).

Warnings/Precautions:

Follow-up if hepatic dysfunction develops. Discontinue and treat appropriately if anaphylactic reactions occur. Pregnancy (Cat.B). Nursing mothers.

Adverse Reactions:

Hypokalemia, GI upset, pyrexia, insomnia, anemia, headache, dyspepsia; hepatic effects, infusion reactions, anaphylactic reactions.

Elimination:

Fecal, renal (minor).

Generic Availability:

NO

How Supplied:

Vial—1